Efficacy and safety evaluation of Fanhdi® , a plasma-derived factor VIII/ von Willebrand factor concentrate, in Von Willebrand's disease patients undergoing surgery or invasive procedures: A prospective clinical study

Efficacy and safety evaluation of Fanhdi^® , a plasma-derived factor VIII/ von Willebrand factor concentrate, in Von Willebrand's disease patients undergoing surgery or invasive procedures: A prospective clinical study

Haemophilia. 2022 Jan;28(1):e23-e27. doi: 10.1111/hae.14453. Epub 2021 Nov 4.

¹ Department of Hematology and Hemotherapy, Hospital Universitario La Paz, Autónoma University, Madrid, Spain.
² Bioscience Research Group, Grifols, Sant Cugat del Vallès, Barcelona, Spain.
³ Hemostasis and Thrombosis Unit, Hematology Service, Hospital Universitari i Politècnic La Fe, Valencia, Spain.
⁴ Department of Haematology and Haemotherapy Luigi Sacco Hospital, Milano, Italy.
⁵ Scientific & Medical Affairs, Grifols, Sant Cugat del Vallès, Barcelona, Spain.

No abstract available